{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:59:47Z","timestamp":1791287987338,"version":"4.3.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"AHRQ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"SAMHSA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005295","name":"American Academy of Pediatrics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005295","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AAP"},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"AHRQ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH"},{"name":"CA"},{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001080","name":"Donaghue Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000133","name":"AHRQ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"AHRQ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaac.2019.04.022","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T10:26:53Z","timestamp":1557311213000},"page":"166-176.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antipsychotic Use Among Youth in Foster Care Enrolled in a Specialized Managed Care Organization Intervention"],"prefix":"10.1016","volume":"59","author":[{"given":"Thomas I.","family":"Mackie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Akincigil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2019.04.022_bib1","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamapsychiatry.2015.0500","article-title":"Treatment of young people with antipsychotic medications in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2019.04.022_bib2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1377\/hlthaff.2016.0064","article-title":"Rapid growth of antipsychotic prescriptions for children who are publicly insured has ceased, but concerns remain","volume":"35","author":"Crystal","year":"2016","journal-title":"Health Affairs"},{"key":"10.1016\/j.jaac.2019.04.022_bib3","doi-asserted-by":"crossref","first-page":"w770","DOI":"10.1377\/hlthaff.28.5.w770","article-title":"Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges","volume":"28","author":"Crystal","year":"2009","journal-title":"Health Affairs"},{"key":"10.1016\/j.jaac.2019.04.022_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ps.201300455","article-title":"Foster care, externalizing disorders, and antipsychotic use among Medicaid-enrolled youths","volume":"65","author":"Vanderwerker","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2019.04.022_bib5","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1056\/NEJMsa1413512","article-title":"Trends in mental health care among children and adolescents","volume":"372","author":"Olfson","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2019.04.022_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1176\/appi.ps.002762012","article-title":"A+KIDS, a web-based antipsychotic registry for North Carolina youths: an alternative to prior authorization","volume":"64","author":"Christian","year":"2013","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2019.04.022_bib7","series-title":"Parameter For the Use of Atypical Antipsychotic Medications in Children and Adolescents","author":"Findling","year":"2011"},{"key":"10.1016\/j.jaac.2019.04.022_bib8","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00702-008-0105-9","article-title":"Weight gain in children and adolescents during 45-weeks treatment with clozapine, olanzapine and risperidone","volume":"115","author":"Fleischhaker","year":"2008","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.jaac.2019.04.022_bib9","author":"Mackie"},{"key":"10.1016\/j.jaac.2019.04.022_bib10","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJMe030040","article-title":"Managing behavioral health in Medicaid","volume":"348","author":"Mechanic","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2019.04.022_bib11","series-title":"How States Structure Medicaid Managed Care to Meet the Unique Needs of Children and Youth with Special Health Care Needs","author":"Honsberger","year":"2018"},{"key":"10.1016\/j.jaac.2019.04.022_bib12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1176\/appi.ps.201700177","article-title":"The impact of a state medicaid peer-review authorization program on pediatric use of antipsychotic medications","volume":"69","author":"Pennap","year":"2018","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2019.04.022_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamapsychiatry.2017.3493","article-title":"Pediatric use of antipsychotic medications before and after medicaid peer review implementation","volume":"75","author":"Zito","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2019.04.022_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40271-018-0299-3","article-title":"Prior authorization as a potential support of patient-centered care","volume":"11","author":"Rand","year":"2018","journal-title":"Patient"},{"key":"10.1016\/j.jaac.2019.04.022_bib15","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1089\/cap.2017.0034","article-title":"Improving cardiometabolic monitoring of children on antipsychotics","volume":"27","author":"Cotes","year":"2017","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2019.04.022_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/appi.ps.201400428","article-title":"The role of clinical setting and management approach in metabolic testing among youths and adults treated with antipsychotics","volume":"67","author":"Nicol","year":"2015","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2019.04.022_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/070674371205700504","article-title":"Metabolic monitoring training program implementation in the community setting was associated with improved monitoring in second-generation antipsychotic-treated children","volume":"57","author":"Ronsley","year":"2012","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jaac.2019.04.022_bib18","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.childyouth.2012.04.006","article-title":"Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care","volume":"34","author":"Rubin","year":"2012","journal-title":"Child Youth Serv Rev"},{"key":"10.1016\/j.jaac.2019.04.022_bib19","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1542\/peds.2007-0212","article-title":"Psychotropic medication patterns among youth in foster care","volume":"121","author":"Zito","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2019.04.022_bib21","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ps.201500270","article-title":"A\u00a0national survey of state Medicaid psychotropic-monitoring programs targeting youths","volume":"67","author":"dosReis","year":"2016","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2019.04.022_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10488-016-0721-x","article-title":"Fostering psychotropic medication oversight for children in foster care: a national examination of states\u2019 monitoring mechanisms","volume":"44","author":"Mackie","year":"2017","journal-title":"Adm Policy Ment Health"},{"key":"10.1016\/j.jaac.2019.04.022_bib23","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.childyouth.2011.07.003","article-title":"Psychotropic medication oversight for youth in foster care: a national perspective on state child welfare policy and practice guidelines","volume":"33","author":"Mackie","year":"2011","journal-title":"Child Youth Serv Rev"},{"key":"10.1016\/j.jaac.2019.04.022_bib24","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2014.16153","article-title":"Methods for evaluating changes in health care policy: the difference-in-differences approach","volume":"312","author":"Dimick","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2019.04.022_bib25","series-title":"Guide to MAX Data: MAX Medicaid Policy Brief 21","author":"Ruttner","year":"2015"},{"key":"10.1016\/j.jaac.2019.04.022_bib26","series-title":"Using Arrays to Calculate Medication Utilization","author":"Leslie","year":"2007"},{"key":"10.1016\/j.jaac.2019.04.022_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamapsychiatry.2016.0538","article-title":"Metabolic testing for adults in a state Medicaid program receiving antipsychotics: remaining barriers to achieving population health prevention goals","volume":"73","author":"Morrato","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2019.04.022_bib28","first-page":"306","article-title":"Permanency and the foster care system","volume":"45","author":"Lockwood","year":"2015","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.jaac.2019.04.022_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2206.2006.00433.x","article-title":"Early outcomes for young adults transitioning from out-of-home care in the USA","volume":"11","author":"Courtney","year":"2006","journal-title":"Child & Family Social Work"},{"key":"10.1016\/j.jaac.2019.04.022_bib30","series-title":"Offending During Late Adolescence: How Do Youth Aging Out of Care Compare With Their Peers?","author":"Cusick","year":"2007"},{"key":"10.1016\/j.jaac.2019.04.022_bib31","series-title":"Pharmaceutical Benefit Management and the Use of Psychotropic Medication for Children and Adolescents","year":"2009"},{"key":"10.1016\/j.jaac.2019.04.022_bib32","first-page":"CD008559","article-title":"Atypical antipsychotics for disruptive behaviour disorders in children and youths","volume":"9","author":"Loy","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaac.2019.04.022_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09540260801889179","article-title":"Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients","volume":"20","author":"Correll","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.jaac.2019.04.022_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1536867X1201200209","article-title":"Using the margins command to estimate and interpret adjusted predictions and marginal effects","volume":"12","author":"Williams","year":"2012","journal-title":"Stata J"},{"issue":"3","key":"10.1016\/j.jaac.2019.04.022_bib35","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3820","article-title":"Medicaid managed care structures and care coordination","volume":"140","author":"Gilchrist-Scott","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2019.04.022_bib36","article-title":"Medicaid managed care and the health care utilization of foster children","volume":"54","author":"Palmer","year":"2017","journal-title":"Inquiry"},{"key":"10.1016\/j.jaac.2019.04.022_bib37","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1176\/appi.ps.201300574","article-title":"Second-generation antipsychotic use among stimulant-using children, by organization of medicaid mental health","volume":"65","author":"Saloner","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2019.04.022_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2307\/3350312","article-title":"Management of mental health and substance abuse services: state of the art and early results","volume":"73","author":"Mechanic","year":"1995","journal-title":"Milbank Q"},{"key":"10.1016\/j.jaac.2019.04.022_bib39","series-title":"Experimental and Quasi-Experimental Designs for Generalized Causal Inferences","author":"Shadish","year":"2002"},{"key":"10.1016\/j.jaac.2019.04.022_bib40","first-page":"163","article-title":"Best practices for mental health in child welfare: screening, assessment, and treatment guidelines","volume":"88","author":"Romanelli","year":"2009","journal-title":"Child Welfare"},{"key":"10.1016\/j.jaac.2019.04.022_bib41","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/archinte.159.19.2263","article-title":"Lying for patients: physician deception of third-party payers","volume":"159","author":"Freeman","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaac.2019.04.022_bib42","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaac.2014.05.008","article-title":"Risperidone added to parent training and stimulant medication: effects on attention-deficit\/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression","volume":"53","author":"Gadow","year":"2014","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2019.04.022_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaac.2013.09.022","article-title":"What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit\/hyperactivity disorder?","volume":"53","author":"Aman","year":"2014","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2019.04.022_bib44","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s10488-013-0495-3","article-title":"A\u00a0multi-state study on mental health evaluation for children entering foster care","volume":"41","author":"Hayek","year":"2014","journal-title":"Admn Policy Ment Health"},{"key":"10.1016\/j.jaac.2019.04.022_bib45","first-page":"1","article-title":"Trends and intervention results for unusual antipsychotic polypharmacy prescribing patterns for Florida adult and child medicaid population: 2007-2013","volume":"42","author":"Lee","year":"2016","journal-title":"J\u00a0Health Care Finance"},{"key":"10.1016\/j.jaac.2019.04.022_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1176\/appi.ps.201400130","article-title":"Use of quality measures for Medicaid behavioral health services by state agencies: implications for health care reform","volume":"66","author":"Seibert","year":"2015","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2019.04.022_bib47","series-title":"State Medicaid Managed Care Enrollment Designs for Children and Youth With Special Health Care Needs: A 50-State Review of Managed Care Contracts","author":"Honsberger","year":"2017"},{"key":"10.1016\/j.jaac.2019.04.022_bib48","series-title":"Florida Moves to Manage Health Care For Foster Kids","author":"Evans","year":"2014"},{"key":"10.1016\/j.jaac.2019.04.022_bib49","series-title":"Return on Investment in Systems of Care For Children With Behavioral Health Challenges","author":"Stroul","year":"2014"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856719303156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856719303156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:27:03Z","timestamp":1760192823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856719303156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0890856719303156"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2019.04.022","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic Use Among Youth in Foster Care Enrolled in a Specialized Managed Care Organization Intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2019.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92019 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}